𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus

✍ Scribed by Wayne A. Phillips; Sarah E. Russell; Marianne L. Ciavarella; David Y.H. Choong; Karen G. Montgomery; Katherine Smith; Richard B. Pearson; Robert J.S. Thomas; Ian G. Campbell

Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
81 KB
Volume
118
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Mutation of PIK3CA, the gene coding for the p110α catalytic subunit of phosphoinositide 3‐kinase (PI3K), has been reported in a limited range of human tumors. We now report that PIK3CA is also mutated in esophageal tumors. Single‐strand conformational polymorphism (SSCP) and denaturing high‐performance liquid chromatography (DHPLC) were used to screen all 20 exons of PIK3CA in 101 samples from 95 individuals with esophageal cancer and/or Barrett's esophagus. Somatic mutation of PIK3CA was detected in 4 of 35 (11.8%) of esophageal squamous cell carcinomas (SCC) and 3 of 50 (6%) adenocarcinomas. No mutations were detected in any of 17 samples of Barrett's esophagus. For PIK3CB, we screened exons 11 and 22, which code for the regions corresponding to the exon 9 and 20 mutational ‘hotspots’ of PIK3CA. No somatic changes were detected in PIK3CB This study extends previous observations in other tumor types by demonstrating the presence of somatic PIK3CA mutations in both SCC and adenocarcinoma of the esophagus, thus implicating the PI3K pathway in the initiation and/or progression of esophageal cancers. © 2005 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Phosphorylated AKT expression is associa
Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers
✍ Yoshifumi Baba; Katsuhiko Nosho; Kaori Shima; Marika Hayashi; Jeffrey A. Meyerha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB 👁 1 views

## Abstract ## BACKGROUND: AKT (AKT1, AKT2, and AKT3) was a downstream effector of phosphatidylinositide‐3‐kinase (PI3K) and played crucial roles in protein synthesis, cellular metabolism, survival, and proliferation. The PI3K/AKT pathway was commonly activated in human cancers and was recognized

Molecular analysis of the PI3K-AKT pathw
Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: Frequent PIK3CA amplification and AKT phosphorylation
✍ Bjørn I. Bertelsen; Solrun J. Steine; Roar Sandvei; Anders Molven; Ole Didrik La 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 363 KB 👁 1 views

## Abstract Uterine cervical carcinogenesis is probably dependent on cellular genetic damage in addition to the integration of high‐risk HPV DNA in the epithelial cell genome. Gain of chromosome 3q24–29 is commonly observed in cervical neoplasia. The putative oncogene __PIK3CA__ located in this reg

Aberrant methylation of secreted frizzle
Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus
✍ Hongzhi Zou; Julian R. Molina; Jonathan J. Harrington; Neal K. Osborn; Kristie K 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 299 KB 👁 2 views

## Abstract Hypermethylation of secreted frizzled‐related proteins (__SFRP__) genes frequently occurs with several cancers but has not been studied in esophageal adenocarcinoma or its precursor—Barrett's esophagus. To explore the role of __SFRP__ methylation in the neoplastic progression of Barrett

PIK3CA mutation is predictive of poor su
PIK3CA mutation is predictive of poor survival in patients with colorectal cancer
✍ Shunsuke Kato; Satoru Iida; Tetsuro Higuchi; Toshiaki Ishikawa; Yoko Takagi; Mas 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 464 KB 👁 1 views

## Abstract The PI3K‐AKT pathway is activated in a variety of human cancers, resulting in disturbance of cell growth, proliferation and survival. Among the factors affecting the pathway, the __K‐Ras__ mutation and __PIK3CA__ mutation are the most common oncogenic alterations in colorectal cancer. W

Inducible nitric oxide synthase, nitroty
Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinoma
✍ Nadine M. Vaninetti; Laurette Geldenhuys; Geoffrey A. Porter; Harvey Risch; Pier 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

## Abstract Nitric oxide (NO) has been implicated as a potential causative factor for endogenous p53 mutations in gastrointestinal malignancy. To investigate the role of NO in esophageal adenocarcinoma (EADC), we studied patterns of p53 mutations, expression of inducible nitric oxide synthase (iNOS